Human BMP-9 Propeptide Antibody Summary
Lys23-Arg319
Accession # Q9UK05
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: BMP-9
Human BMP-9, also known as growth and differentiation factor 2 (GDF-2), is a member of the BMP subgroup of the TGF-beta superfamily proteins that signal through heterodimeric complexes composed of type I and type II BMP receptors. BMP-9 regulates the development and function of a variety of embryonal and adult tissues (1, 2). The human BMP-9 cDNA encodes a 429 amino acid (aa) precursor that includes a 22 aa signal sequence, a 298 aa propeptide, and a 111 aa mature protein (3). Unlike with other BMP family proteins, the propeptide does not interfere with the biological activity of BMP-9 and remains associated with the mature peptide after proteolytic cleavage (4). Human and mouse BMP-9 share 96% aa sequence identity. Within the mature protein, human BMP-9 shares 64% aa sequence identity with human BMP-10 and less than 50% aa sequence identity with other BMPs. BMP-9 is expressed by non-parenchymal cells in the liver, (5, 6) where it promotes lipid metabolism and inhibits glucose production (7). BMP-9 exerts a prolonged hypoglycemic effect which may be due to an enhancement of insulin release (7). BMP-9 interacts with a high affinity specific heteromeric receptor expressed on liver endothelial cells that has been identified as ALK-1 (4‑6). In the embryonal CNS, BMP-9 functions in the development and maintenance of the cholinergic neuronal phenotype (8‑10). BMP-9 also induces the differentiation of mesenchymal stem cells into the chondrogenic lineage (11, 12). At low concentrations, BMP-9 is a proliferative factor for hematopoietic progenitor cells, but at higher concentrations, it enhances TGF-beta 1 production and inhibits hematopoietic progenitor colony formation (13).
- Chen, D. et al. (2004) Growth Factors 22:233.
- Miyazono, K. et al. (2005) Cytokine Growth Factor Rev. 16:251.
- Celeste, A.J. et al. (1994) J. Bone Miner. Res. 9:S136.
- Brown, M.A. et al. (2005) J. Biol. Chem. 280:25111.
- Song, J.J. et al. (1995) Endocrinology 136:4293.
- Miller, A.F. et al. (2000) J. Biol. Chem. 275:17937.
- Chen, C. et al. (2003) Nat. Biotechnol. 21:294.
- Lopez-Coviella, I. et al. (2000) Science 289:313.
- Lopez-Coviella, I. et al. (2005) Proc. Natl. Acad. Sci. 102:6984.
- Lopez-Coviella, I. et al. (2002) J. Physiol. Paris 96:53.
- Majumdar, M.K. et al. (2001) J. Cell. Physiol. 189:275.
- Hills, R.L. et al. (2005) J. Orthoped. Res. 23:611.
- Ploemacher, R.E. et al. (1999) Leukemia 13:428.
Product Datasheets
Citations for Human BMP-9 Propeptide Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
5
Citations: Showing 1 - 5
Filter your results:
Filter by:
-
Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure
Authors: Kevin J. Morine, Xiaoying Qiao, Sam York, Peter S. Natov, Vikram Paruchuri, Yali Zhang et al.
Circulation
-
Preferential Induction of the T Cell Auxiliary Signaling Molecule B7-H3 on Synovial Monocytes in Rheumatoid Arthritis
Authors: BR Yoon, YH Chung, SJ Yoo, K Kawara, J Kim, IS Yoo, CG Park, SW Kang, WW Lee
J. Biol. Chem, 2015-12-23;291(8):4048-57.
Species: Human
Sample Types: Protein
Applications: ELISA Development (Capture) -
Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains
Authors: Y Kienast, U Jucknischk, S Scheiblich, M Thier, M de Wouters, A Haas, C Lehmann, V Brand, D Bernicke, K Honold, S Lorenz
J. Biol. Chem, 2015-12-16;291(7):3395-410.
Species: Human
Sample Types: Protein
Applications: ELISA Development (Capture) -
Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an “HHT‐like” syndrome in children
Authors: Joshua Hodgson, Lidia Ruiz‐Llorente, Jamie McDonald, Oliver Quarrell, Kelechi Ugonna, James Bentham et al.
Molecular Genetics & Genomic Medicine
-
Regulation of Bone Morphogenetic Protein 9 (BMP9) by Redox-dependent Proteolysis*
Authors: Zhenquan Wei, Richard M. Salmon, Paul D. Upton, Nicholas W. Morrell, Wei Li
Journal of Biological Chemistry
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human BMP-9 Propeptide Antibody
There are currently no reviews for this product. Be the first to review Human BMP-9 Propeptide Antibody and earn rewards!
Have you used Human BMP-9 Propeptide Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image